Gefitinib is a drug that helps with NSCLC. It targets certain genetic changes, like the ones in exon 19 or the L858R mutations in exon 21. It goes after the EGFR pathway.
The medicine comes in 250 mg film-coated tablet form. You’re supposed to take 250 mg of it, every day, regardless of whether you’re eating or not. It’s usually packed in bottles that hold 30 tablets.
It works by blocking EGFR signals. You’ll find it in bottles of 30 tablets. Each pill is a film-coated tablet, and they’re 250 mg strong.
You’ll need to take 250 mg of it each day. Each bottle can hold 30 pills.